Proof of Usefulness Report

Blacksand Therapeutics

Analysis completed on 3/11/2026

+41

Proof of Usefulness Score

You're In Business

Blacksand Therapeutics operates in a promising and highly relevant sector (AI-driven precision therapeutics for mental health), but severely lacks credible evidence of traction. Claims such as 'most people have used my product' are verifiably false for an early-stage 2021 biotech startup with a reported market cap of 500,000. The project demonstrates potential technical innovation but scores very low on audience reach, evidence of traction, and response quality due to exaggerated and unsupported assertions.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+15.0

Audience Reach Impact+1.0

Technical Innovation+10.5

Evidence Of Traction+0.6

Market Timing Relevance+8.0

Functional Completeness+0.5

Subtotal+35.6

Usefulness Multiplierx1.15

Final Score+41

Project Details

Project URL

blacksandtherapeutics.com

Description

Blacksand Therapeutics is a London-based startup biotech that is focused on using a multifactorial AI approach to integrate phenotypic and neurochemical profiles with ligand overlays to discover and develop a new class of precision therapeutics for the treatment of Mental Health Disorders

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline